Ads
related to: does strattera help with focus- Dosing & Administration
Learn About a Once-Daily Dosing
Option for ADHD Patients.
- ADHD in Adult Patients
Access Resources for Diagnosing
& Treating ADHD in Adult Patients.
- Pediatric ADHD Patients
Resources for Diagnosing & Treating
ADHD in Pediatric Patients.
- Important Safety Info
Review Important Safety, Dosing,
& Tolerability Information.
- Prescriber Resources
Continued Access & Support for
Physicians & Patients Available.
- Review Clinical Studies
Read Clinical Trial Data for a
Nonstimulant ADHD Treatment Option.
- Dosing & Administration
Search results
Results From The WOW.Com Content Network
Atomoxetine, formerly sold under the brand name Strattera, [12] is a selective norepinephrine reuptake inhibitor (sNRI) medication used to treat attention deficit hyperactivity disorder (ADHD) [13] and, to a lesser extent, cognitive disengagement syndrome (CDS). [14] [15] [16] It may be used alone or along with stimulant medication.
More specifically, it looked at the effect of methylphenidate (brand names Ritalin, Concerta), a stimulant, and atomoxetine (Strattera), a non-stimulant, on the brain.
Atomoxetine is sold under the brand name Strattera and was first approved for medical use in the United States in 2002. [1] Its indication is for the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age, adolescents and adults. [2]
Attention deficit hyperactivity disorder management options are evidence-based practices with established treatment efficacy for ADHD.Approaches that have been evaluated in the management of ADHD symptoms include FDA-approved pharmacologic treatment and other pharmaceutical agents, psychological or behavioral approaches, combined pharmacological and behavioral approaches, cognitive training ...
The slow and long-acting nonstimulant atomoxetine (Strattera), is primarily a norepinephrine reuptake inhibitor and, to a lesser extent, a dopamine reuptake inhibitor. [14] It is sometimes prescribed in adults who do not get enough vigilant concentration response from mixed amphetamine salts (Adderall) or get too many side effects.
In April 2014, The New York Times reported that sluggish cognitive tempo is the subject of pharmaceutical company clinical drug trials, including ones by Eli Lilly that proposed that one of its biggest-selling drugs, Strattera, could be prescribed to treat proposed symptoms of sluggish cognitive tempo. [57]
Ad
related to: does strattera help with focus